Microlin Bio (Microlin Bio) Total Long-Term Assets : $0.00 Mil (As of Sep. 2015)

View and export this data going back to 2014. Start your Free Trial

What is Microlin Bio Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Microlin Bio's Total Long-Term Assets for the quarter that ended in Sep. 2015 was $0.00 Mil.

Microlin Bio Total Long-Term Assets Historical Data

The historical data trend for Microlin Bio's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microlin Bio Total Long-Term Assets Chart

Microlin Bio Annual Data

Trend

Dec12

Dec13

Dec14

Total Long-Term Assets

Microlin Bio Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Long-Term Assets	Get a 7-Day Free Trial									-	-	-	-	-

Microlin Bio Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Microlin Bio Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Microlin Bio's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Microlin Bio (Microlin Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microlin Bio Inc (GREY:MICB) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.microlinbio.com

MicroLin Bio Inc is engaged in the healthcare sector. It is a therapeutic and diagnostic company focusing on microRNA and its role in oncology. MicroRNAs represent a class of diagnostics and therapeutics that are more effective in the diagnosis and treatment of cancer, with the potential for mitigating side effects in comparison with conventional small molecule drugs or biologics. The company's properties include molecular diagnostics and companion tests, cancer therapeutics, and delivery platform technology. Molecular diagnostics & companion tests include tests such as Lumira, Omira, Colomira, and Promira. Cancer therapeutics includes lumiralin, omiralin, colomiralin, and promirali.

Microlin Bio (Microlin Bio) Headlines

No Headlines